- Abstract Number: 0942
G Protein-coupled Receptor Kinase 5 in Fibrotic Tissue Remodeling
- Abstract Number: 2247
Gender Differences in Switching Biological and Targeted Synthetic Therapies in Psoriatic Arthritis
- Abstract Number: 2217
Gender Disparities in Disease Activity Scores and Treatment Response Among Patients with Axial Spondyloarthritis
- Abstract Number: 0170
Gender Equity Amongst Rheumatology Professionals: Preliminary Findings of the Coalition for Health and Gender Equity E-survey (CHANGE Group)
- Abstract Number: 2450
Gene by Respiratory Disease Interactions Associated with Developing Rheumatoid Arthritis
- Abstract Number: 1146
Gene X Environment Paradigm: Exemplified by Selected Cases of Autoinflammatory Diseases
- Abstract Number: 2016
Generation of a Human 3D in Vitro Bone Model That Mimics Glucocorticoid-induced Osteoporosis
- Abstract Number: 1710
Genetic Associations in Juvenile Idiopathic Arthritis Determined with an Electronic Health Record Based Approach
- Abstract Number: 0560
Genetic Determinants of Lupus Nephritis and Kidney Function in Systemic Lupus Erythematosus
- Abstract Number: 0015
Genetic Predisposition to a Positive Antinuclear Antibody Test Is Not Associated with Increased Risk of Disease
- Abstract Number: 2115
Genetic Risk Load as a Predictor of Radiographic Damage and Mortality in Female Patients with Rheumatoid Arthritis
- Abstract Number: 0930
Genetic Risk Profiles of Patients with Lupus Nephritis to Identify Those at Risk for Kidney Deterioration and Eventual Damage
- Abstract Number: 1109
Genetic Risk Variants in Hyperuricemia and Gout: Common Disease, Multiple Common and Rare Variant Hypothesis
- Abstract Number: 0034
Genome-Wide Association Study for Loci Associated with Positive Antinuclear Antibodies in a Large Hospital Biobank
- Abstract Number: 1616
Geographic and Demographic Representation in Industry-sponsored, US-based Clinical Trials of Systemic Lupus Erythematosus Therapies
- Abstract Number: 1031
Geographic Socioeconomic Influences on Disease Activity in Rheumatoid Arthritis in an Academic and Safety-Net Hospital System
- Abstract Number: 1817
Geographic Variability of Inflammatory Bowel Disease Related Mortality, 1999-2019; CDC WONDER
- Abstract Number: 2415
Giant Cell Arteritis Is Associated with Worse Hospital Outcomes in Aortic Aneurysm/Dissection Hospitalizations: A Nationwide United States Population-Based Study
- Abstract Number: 0733
Global Identification of Lupus Genetic Risk Variants Facilitating the Type I Interferon Pathway Through CRISPR-based Genomic Screening
- Abstract Number: 0715
Glucocorticoid Toxicity in Patients with IgG4-Related Disease Within the First Year of Treatment
- Abstract Number: 2141
Glucocorticoid Treatment in Early Rheumatoid Arthritis Is Associated with Increased Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Levels: A Post-hoc Analysis of a Randomized Controlled Trial (NORD-STAR)
- Abstract Number: 0447
Glucocorticoid Use in Rheumatoid Arthritis Patients Initiating Biological or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs (b/tsDMARDs) in Real Life: Data from BIOBADASER
- Abstract Number: 1446
Glucocorticoids Use Is a Major Driver of Self-perceived Depression in Systemic Lupus Erythematosus: Insights from a Large, Prospective and Multicenter Study Using RELESSERPROS Register’s Database
- Abstract Number: 0059
GM-CSF by Natural Killer Cells Drives Inflammatory Arthritis in HIV-Infected Humanized Mice
- Abstract Number: 0057
GM-CSF receptor/SYK/JNK/FOXO1/CD11c Signaling Enhances Cell Migration to Promote Atherosclerosis
- Abstract Number: 2032
Goal Concordance in Rheumatoid Arthritis Patients with Depression – What Do Patients Prioritize?
- Abstract Number: 1202
Goal Concordant Patient-clinician Dyads Have Higher Odds of Communication Around Rheumatoid Arthritis Goals
- Abstract Number: 1793
Goblet Cell Specific Anti-Apoptotic Role of Interleukin-24 in Spondyloarthritis-Associated Ileitis
- Abstract Number: 0241
Gout Flares During the Initiation and Escalation of Treat-to-Target Urate Lowering Therapy: A Post-hoc Analysis of a Randomized Multicenter Comparative Effectiveness Trial
- Abstract Number: 0240
Gout: A Gateway to Chronic Opioid Use?
- Abstract Number: 0094
Granzyme K Elicits a New Pathway for Complement Activation in RA Synovium
- Abstract Number: 0955
GRB2 Serves as a Viable Target Against Skin Fibrosis in Systemic Sclerosis by Regulating Endothelial Cell Apoptosis
- Abstract Number: 2241
Guselkumab Efficacy in Active Psoriatic Arthritis Patients with or Without Hyperuricemia: Post-hoc Analysis of Two Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
- Abstract Number: 1428
Guselkumab Provides Clinically Meaningful Improvents in Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis Who Are Inadequate Responders to Tumour Necrosis Factor Inhibitors: Results Through One Year of a Phase 3b, Randomized, Controlled Study (COSMOS)
- Abstract Number: 2236
Guselkumab Provides Rapid Clinically Meaningful Improvements in Clinical and Patient Reported Outcomes and Sustained Disease Control of Psoriatic Arthritis
- Abstract Number: 2232
Guselkumab, an IL-23p19 Subunit–specific Monoclonal Antibody, Is Able to Bind CD64+ Myeloid Cells, Potently Neutralize IL-23 Produced from the Cells, and Mediate Internalization of IL-23
- Abstract Number: 2584
Gut Microbiome and Intestinal Inflammation in Preclinical Stages of Rheumatoid Arthritis
- Abstract Number: 1774
Gut Microbiota and Permeability Biomarkers for Diagnosis and Prognosis in Rheumatoid Arthritis Associated Interstitial Lung Disease
- Abstract Number: 1730
Gut Microbiota Dysbiosis Impact Autonomic Function in Rheumatoid Arthritis Patients
ACR Convergence 2023
November 10-15, 2023. San Diego, CA.